These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 20950980)

  • 1. The percutaneous ventricular assist device in severe refractory cardiogenic shock.
    Kar B; Gregoric ID; Basra SS; Idelchik GM; Loyalka P
    J Am Coll Cardiol; 2011 Feb; 57(6):688-96. PubMed ID: 20950980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation.
    Idelchik GM; Simpson L; Civitello AB; Loyalka P; Gregoric ID; Delgado R; Kar B
    J Heart Lung Transplant; 2008 Jan; 27(1):106-11. PubMed ID: 18187095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock.
    Burkhoff D; Cohen H; Brunckhorst C; O'Neill WW;
    Am Heart J; 2006 Sep; 152(3):469.e1-8. PubMed ID: 16923414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials.
    Cheng JM; den Uil CA; Hoeks SE; van der Ent M; Jewbali LS; van Domburg RT; Serruys PW
    Eur Heart J; 2009 Sep; 30(17):2102-8. PubMed ID: 19617601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock.
    Thiele H; Sick P; Boudriot E; Diederich KW; Hambrecht R; Niebauer J; Schuler G
    Eur Heart J; 2005 Jul; 26(13):1276-83. PubMed ID: 15734771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience and patient outcomes associated with the TandemHeart percutaneous transseptal assist device among a heterogeneous patient population.
    Tempelhof MW; Klein L; Cotts WG; Benzuly KH; Davidson CJ; Meyers SN; McCarthy PM; Malaisrie CS; McGee EC; Beohar N
    ASAIO J; 2011; 57(4):254-61. PubMed ID: 21546824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraaortic balloon pumping in patients with right ventricular insufficiency after cardiac surgery: parameters to predict failure of IABP Support.
    Boeken U; Feindt P; Litmathe J; Kurt M; Gams E
    Thorac Cardiovasc Surg; 2009 Sep; 57(6):324-8. PubMed ID: 19707972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timely use of a CentriMag heart assist device improves survival in postcardiotomy cardiogenic shock.
    Akay MH; Gregoric ID; Radovancevic R; Cohn WE; Frazier OH
    J Card Surg; 2011 Sep; 26(5):548-52. PubMed ID: 21951040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility study of the use of the TandemHeart percutaneous ventricular assist device for treatment of cardiogenic shock.
    Burkhoff D; O'Neill W; Brunckhorst C; Letts D; Lasorda D; Cohen HA
    Catheter Cardiovasc Interv; 2006 Aug; 68(2):211-7. PubMed ID: 16819767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Short and intermediate term clinical outcome in patients with cardiogenic shock treated with aortic counterpulsation].
    Fornaro G; Prando MD; Parodi F; Cordero G; Sansa M; Bongo AS; Campi A; Aralda D; Dellavesa P; Aina F; Lazzero M; Cernigliaro C
    G Ital Cardiol; 1996 Dec; 26(12):1385-99. PubMed ID: 9162668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a percutaneous left ventricular assist device for high-risk cardiac interventions and cardiogenic shock.
    Thomas JL; Al-Ameri H; Economides C; Shareghi S; Abad DG; Mayeda G; Burstein S; Shavelle DM
    J Invasive Cardiol; 2010 Aug; 22(8):360-4. PubMed ID: 20679671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous left ventricular assist devices for treatment of patients with cardiogenic shock.
    Windecker S
    Curr Opin Crit Care; 2007 Oct; 13(5):521-7. PubMed ID: 17762230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with the TandemHeart percutaneous ventricular assist device as a bridge to cardiac transplantation.
    Bruckner BA; Jacob LP; Gregoric ID; Loyalka P; Kar B; Cohn WE; La Francesca S; Radovancevic B; Frazier OH
    Tex Heart Inst J; 2008; 35(4):447-50. PubMed ID: 19156239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial experiences with the Impella device in patients with cardiogenic shock - Impella support for cardiogenic shock.
    Meyns B; Dens J; Sergeant P; Herijgers P; Daenen W; Flameng W
    Thorac Cardiovasc Surg; 2003 Dec; 51(6):312-7. PubMed ID: 14669126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanical circulatory support devices improve tissue perfusion in patients with end-stage heart failure or cardiogenic shock.
    den Uil CA; Maat AP; Lagrand WK; van der Ent M; Jewbali LS; van Thiel RJ; Spronk PE; Simoons ML
    J Heart Lung Transplant; 2009 Sep; 28(9):906-11. PubMed ID: 19716043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seven years' experience with the Pierce-Donachy ventricular assist device.
    Pennington DG; Kanter KR; McBride LR; Kaiser GC; Barner HB; Miller LW; Naunheim KS; Fiore AC; Willman V
    J Thorac Cardiovasc Surg; 1988 Dec; 96(6):901-11. PubMed ID: 3057290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous right ventricular assist via the internal jugular vein in cardiogenic shock complicating an acute inferior myocardial infarction.
    Kiernan MS; Krishnamurthy B; Kapur NK
    J Invasive Cardiol; 2010 Feb; 22(2):E23-6. PubMed ID: 20124598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of prolonged intra-aortic balloon pumping in patients with cardiogenic shock following acute myocardial infarction.
    Li JL; Xue H; Wang BS; Zhang HY; Yin LH; Shun WD; Wu Y; Wang LX
    Med Sci Monit; 2007 Jun; 13(6):CR270-74. PubMed ID: 17534233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.
    Seyfarth M; Sibbing D; Bauer I; Fröhlich G; Bott-Flügel L; Byrne R; Dirschinger J; Kastrati A; Schömig A
    J Am Coll Cardiol; 2008 Nov; 52(19):1584-8. PubMed ID: 19007597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-Aortic Balloon Counterpulsation in Patients With Chronic Heart Failure and Cardiogenic Shock: Clinical Response and Predictors of Stabilization.
    Sintek MA; Gdowski M; Lindman BR; Nassif M; Lavine KJ; Novak E; Bach RG; Silvestry SC; Mann DL; Joseph SM
    J Card Fail; 2015 Nov; 21(11):868-76. PubMed ID: 26164215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.